1,165
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

YKL-40 promotes proliferation and invasion of HTR-8/SVneo cells by activating akt/MMP9 signalling in placenta accreta spectrum disorders

, , , , , & show all
Article: 2211681 | Received 13 Feb 2023, Accepted 03 May 2023, Published online: 16 May 2023

References

  • Allen, L., et al., 2018. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 140 (3), 281–290.
  • Bian, B., et al., 2019. Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies. Cancer Cell International, 19, 259.
  • Böckelmann, L.C., et al., 2021. YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models. Cellular Oncology, 44 (5), 1183–1195.
  • Chen, H.Y., et al., 2021. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer. Cell Biology International, 45 (12), 2557–2566.
  • Ding, J., et al., 2021. M2 macrophage-derived G-CSF promotes trophoblasts EMT, invasion and migration via activating PI3K/Akt/Erk1/2 pathway to mediate normal pregnancy. Journal of Cellular and Molecular Medicine, 25 (4), 2136–2147.
  • Gözükara, İ., et al., 2017. YKL-40 expression in abnormal invasive placenta cases. Journal of Perinatal Medicine, 45, 571–575.
  • Graham, C.H., et al., 1993. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Experimental Cell Research, 206 (2), 204–211.
  • Guvenir, H., et al., 2021. Can serum periostin, YKL-40, and osteopontin levels in pre-school children with recurrent wheezing predict later development of asthma? Pediatric Allergy and Immunology : official Publication of the European Society of Pediatric Allergy and Immunology, 32 (1), 77–85.
  • Hao, H., et al., 2021. YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition. Ann Med, 53, 1170–1178.
  • Illsley, N.P., et al., 2020. Trophoblast invasion: lessons from abnormally invasive placenta (placenta accreta). Placenta, 102, 61–66.
  • Jauniaux, E., Collins, S. and Burton, G.J., 2018. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. American Journal of Obstetrics and Gynecology, 218 (1), 75–87.
  • Jefri, M., et al., 2015. YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer. BMC Cancer, 15, 590.
  • Jiang, H. and Li, H., 2021. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis. BMC Cancer, 21 (1), 149.
  • Johansen, J.S., et al., 1992. Identification of proteins secreted by human osteoblastic cells in culture. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 7 (5), 501–512.
  • Kohan-Ghadr, H.R., et al., 2016. Potential role of epigenetic mechanisms in regulation of trophoblast differentiation, migration, and invasion in the human placenta. Cell Adhesion & Migration, 10 (1-2), 126–135.
  • Larionova, I., et al., 2020. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers. Frontiers in Oncology, 10, 566511.
  • Li, L.L., et al., 2016. Effects of a small interfering RNA targeting YKL-40 gene on the proliferation and invasion of endometrial cancer HEC-1A cells. International Journal of Gynecological Cancer : official Journal of the International Gynecological Cancer Society, 26 (7), 1190–1195.
  • Liu, L., et al., 2021. CHI3L2 Is a novel prognostic biomarker and correlated with immune infiltrates in gliomas. Frontiers in Oncology, 11, 611038.
  • Liu, Y., et al., 2020. Knockdown of activated Cdc42-associated kinase inhibits human extravillous trophoblast migration and invasion and decreases protein expression of pho-Akt and matrix metalloproteinase. The Journal of Maternal-Fetal & Neonatal Medicine, 33 (7), 1125–1133.
  • Long, Y., et al., 2020. The expression and biological function of chemokine CXCL12 and receptor CXCR4/CXCR7 in placenta accreta spectrum disorders. Journal of Cellular and Molecular Medicine, 24 (5), 3167–3182.
  • Madazli, R., et al., 2008. Chitotriosidase and YKL-40 in normal and pre-eclamptic pregnancies. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 100 (3), 239–243.
  • Miller, R., Timor-Tritsch, I.E. and Gyamfi-Bannerman, C, 2020. Society for maternal-fetal medicine (SMFM) consult series #49: Cesarean scar pregnancy. American Journal of Obstetrics and Gynecology, 222 (5), B2–b14.
  • Mogos, M.F., et al., 2016. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998–2011. The Journal of Maternal-Fetal & Neonatal Medicine, 29 (7), 1077–1082.
  • Moser, G., et al., 2018. Human trophoblast invasion: new and unexpected routes and functions. Histochemistry and Cell Biology, 150 (4), 361–370.
  • Oğlak, S.C., Ölmez, F. and Tunç, Ş., 2022. Evaluation of antepartum factors for predicting the risk of emergency cesarean delivery in pregnancies complicated with placenta previa. The Ochsner Journal, 22 (2), 146–153.
  • Oh, I.H., Pyo, J.S. and Son, B.K., 2021. Prognostic impact of YKL-40 immunohistochemical expression in patients with colorectal cancer. Current Oncology (Toronto, Ont.), 28 (4), 3139–3149.
  • Ozkose, Z.G., et al., 2022. Maternal serum cripto-1 levels in pregnancies complicated with placenta previa and placenta accreta spectrum (PAS). J Coll Physicians Surg Pak, 32, 1570–1575.
  • Pan, X.Y., et al., 2015. A marked increase in obstetric hysterectomy for placenta accreta. Chinese Medical Journal, 128 (16), 2189–2193.
  • Puthumana, J., et al., 2021. Biomarkers of inflammation and repair in kidney disease progression. J Clin Invest, 131 (3), e139927.
  • Raeeszadeh-Sarmazdeh, M., Do, L.D. and Hritz, B.G., 2020. Metalloproteinases and their inhibitors: potential for the development of new therapeutics. Cells, 9 (5), 1313.
  • Wang, L., et al., 2019a. Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia. Placenta, 87, 38–45.
  • Wang, N., et al., 2020. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling. Biomedicine & Pharmacotherapy, 123, 109729.
  • Wang, Q., et al., 2019b. Down-regulated long non-coding RNA PVT1 contributes to gestational diabetes mellitus and preeclampsia via regulation of human trophoblast cells. Biomedicine & Pharmacotherapy, 120, 109501.
  • Wang, Y., et al., 2018. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma. Cancer Letters, 429, 54–65.
  • Weiniger, C.F., 2020. What’s new in obstetric anesthesia in 2018? International Journal of Obstetric Anesthesia, 42, 99–108.
  • Weiss, G., et al., 2016. Arterial endothelial cytokines guide extravillous trophoblast invasion towards spiral arteries; an in-vitro study with the trophoblast cell line ACH-3P and female non-uterine endothelial cells. Placenta, 38, 49–56.
  • Xu, B., et al., 2019a. FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/β-catenin signaling pathway. Biochemical Pharmacology, 163, 234–249.
  • Xu, Y., et al., 2019b. ANXA4 promotes trophoblast invasion via the PI3K/Akt/eNOS pathway in preeclampsia. American Journal of Physiology. Cell Physiology, 316 (4), C481–c491.
  • Yeo, I.J., et al., 2019. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacology & Therapeutics, 203, 107394.
  • Zhang, B., et al., 2020. Identification of prognostic biomarkers for multiple solid tumors using a human villi development model. Frontiers in Cell and Developmental Biology, 8, 492.
  • Zhu, X., et al., 2016. Knockdown of TACC3 inhibits trophoblast cell migration and invasion through the PI3K/Akt signaling pathway. Molecular Medicine Reports, 14 (4), 3437–3442.